Google Translate provides automated translation for this web site. Some content cannot be translated and none should be considered exact. CareOregon is not responsible for the accuracy of the translation.
Regular updates for provider resources will be available on this page.
November 17, 2011
Effective January 1, 2012, several drugs will be removed from CareOregon Advantage (Medicare) formulary. The table includes some of the drugs being removed and formulary alternatives. We want to avoid any disruption to therapy. Current members who will be affected by negative changes will be given a 60-day transition supply during the first 90 days of the new plan year. We will also be contacting prescribers who have members affected by select changes before the end of 2011 to help them make the transition to formulary alternatives or request an exception.
In addition to these changes, some drugs now will have quantity limits or require prior authorization or step therapy. Please refer to the 2012 CareOregon Advantage Formulary, Prior Authorization Criteria, Quantity Limits, and Step Therapy Criteria.
Omeprazole Rx (capsule) and pantoprazole
Zomig and Axert
Sumatriptan and naratriptan
Alora, Combipatch, Climara Pro, Activella
Estradiol tablet/patch, estropipate, estrogen creams, Prefest
Epogen
Procrit and Aranesp with prior authorization
Fexofenadine (only Rx covered until supply runs out)
Loratadine, cetirizine and levocetirizine
Additional Resources for Providers
Best Practices and Health Promotions
Provider Forms and Policies
Medicaid Management Information System (MMIS) through the DHS
Formulary Updates
Quality Improvement Program Summary 2010
Partners and Programs
Care Support and System Innovation (CSSI)
Primary Care Renewal
